THE USE OF MELOXICAM (MOVALIS) AND ACECLOFENAC (AERTALA) BY ELDERLY PATIENTS WITH OSTEOARTHRITIS

Zamyatina Ekaterina Alexandrovna, Postgraduate student, Orenburg State Medical Academy, zamyatina.katerina@yandex.ru
Bagirova Genrietta Georgievna, Doctor of medical sciences, professor, head of sub-department of polyclinic therapy, Orenburg State Medical Academy, bagirowa@yandex.ru

616.72-002

The research includes data of the clinical examination of elderly people with osteoarthritis (фпу average 64,4 ± 7,8) taking Meloxicam (movalis) and Aceclofenac (Airtal). Meloxicam (movalis) has been prescribed 7,5 mg 2 times a day for 10 days, Aceclofenac (Airtal) – 100 mg 2 times a day for the same period of time. Patients underwent standard arthrological and paraclinical examinations. Roentgenological and ultrasonic examinations of the affected joints were also carried out. The state of the patients has been evaluated according to VAS and WOMAC scales, defining the index of arthrosis. After the given treatment the patients has noticed the reduce of pain and edema of the affected joints. All the indices under study have reduced equally in both groups. The comparison of these two medicines shows efficiency in treatment of pain and edema of the affected joints, good tolerance and single cases of unfavorable effects.

osteoarthritis, treatment, Meloxicam, Aceclofenac.